9-trifluoromethyl-2-((5-(3-(dimethylamino)propyl)-2-methylpyridin-3-yl)amino)-5,7-dihydro-6H-pyrimido(5,4-d)(1)benzazepine-6-thione,
MLN0905,
MLN0905,
1228960-69-7,
PLK1 Inhibitor,
MLN-0905,
MLN 0905,
2-(5-(3-(DIMETHYLAMINO)PROPYL)-2-METHYLPYRIDIN-3-YLAMINO)-9-(TRIFLUOROMETHYL)-5H-BENZO[B]PYRIMIDO[4,5-D]AZEPINE-6(7H)-THIONE,
2-[[5-[3-(dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,
2-({5-[3-(dimethylamino)propyl]-2-methylpyridin-3-yl}amino)-9-(trifluoromethyl)-5,7-dihydro-6H-pyrimido[5,4-d][1]benzazepine-6-thione,
CODBZFJPKJDNDT-UHFFFAOYSA-N,
GTPL9402,
SCHEMBL2255230,
CHEMBL1945805,
C24H25F3N6S,
DTXSID30673165,
BCP05348,
EX-A2105,
2556AH,
s2898,
ZINC82157362,
AKOS026750606,
CS-1081,
PB23134,
QC-9272,
compound 12c [PMID: 22070629],
NCGC00386384-04,
BC600519,
DA-47020,
HY-15155,
AB0097718,
FT-0726524,
W-5984,
2-((5-(3-(dimethylamino)propyl)-2-methylpyridin-3-yl)amino)-9-(trifluoromethyl)-5,7-dihydro-6H-benzo[b]pyrimido[4,5-d]azepine-6-thione,
2-((5-(3-(Dimethylamino)propyl)-2-methylpyridin-3-yl)amino)-9-(trifluoromethyl)-5H-benzo[b]pyrimido[4,5-d]azepine-6(7H)-thione,
2-({5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl}amino)-9-(trifluoromethyl)-5,7-dihydro-6H-pyrimido[5,4-d][1]-benzazepine-6-thione,
2-[[5-[3-(DIMETHYLAMINO)PROPYL]-2-METHYL-3-PYRIDINYL]AMINO]-5,7-DIHYDRO-9-(TRIFLUOROMETHYL)-6H-PYRIMIDO[5,4-D][1]BENZAZEPINE-6-THIONE,
D05QMQ,
PLK-1 inhibitor (lymphoma), Millennium,
A8680,
A12429,